Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 20/20 | 1.00 |
| ▸ | F2 | P00734 | 13/20 | 1.00 |
| ▸ | F10 | P00742 | 3/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL231899 | 1.00 | F7 (1.00) | F7F2F10 | |
| SCHEMBL4231819 | 0.91 | F7 (0.84) | F7F2F10 | |
| SCHEMBL4231809 | 0.91 | F7 (0.84) | F7F2F10 | |
| SCHEMBL4231817 | 0.91 | F7 (0.84) | F7F2F10 | |
| SCHEMBL3863203 | 0.91 | F7 (0.84) | F7F2F10 | |
| SCHEMBL4958022 | 0.86 | F7 (0.75) | F7F2F10 | |
| SCHEMBL4958055 | 0.86 | F7 (0.75) | F7F2F10 | |
| SCHEMBL13993084 | 0.86 | F7 (0.75) | F7F2F10 | |
| SCHEMBL13936352 | 0.85 | F7 (1.00) | F7F2F10 | |
| SCHEMBL235788 | 0.85 | F7 (1.00) | F7F2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1656158-A2 | LIQUID, AQUEOUS PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDES | Novo Nordisk Health Care AG (CH) | 2006-05-17 | — | — | EP | claimed |
| WO-2005016365-A2 | LIQUID, AQUEOUS PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDES | NOVO NORDISK HEALTH CARE AG (CH) | 2005-02-24 | — | — | WO | claimed |
| EP-2906236-A1 | LIQUID PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDE | Novo Nordisk Health Care AG (CH) | 2015-08-19 | — | — | EP | disclosed |
| EP-1989304-B1 | A METHOD OF REMOVING A NON-METALLIC PROTEIN INHIBITOR FROM A LIQUID PHARMACEUTICAL PREPARATION | NOVO NORDISK HEALTHCARE AG (CH) | 2010-05-05 | — | — | EP | disclosed |
| US-20090111751-A1 | Method of Removing a Non-Metallic Protein Inhibitor From a Liquid Pharmaceutical Preparation | NOVO NORDISK HEALTH CARE AG (CH) | 2009-04-30 | — | — | US | disclosed |
| EP-1989304-A1 | A METHOD OF REMOVING A NON-METALLIC PROTEIN INHIBITOR FROM A LIQUID PHARMACEUTICAL PREPARATION | Novo Nordisk Health Care AG (CH) | 2008-11-12 | — | — | EP | disclosed |
| WO-2007096406-A1 | A METHOD OF REMOVING A NON-METALLIC PROTEIN INHIBITOR FROM A LIQUID PHARMACEUTICAL PREPARATION | NOVO NORDISK HEALTH CARE AG (CH) | 2007-08-30 | — | — | WO | disclosed |
| EP-1656158-A2 | LIQUID, AQUEOUS PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDES | Novo Nordisk Health Care AG (CH) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005016365-A2 | LIQUID, AQUEOUS PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDES | NOVO NORDISK HEALTH CARE AG (CH) | 2005-02-24 | — | — | WO | disclosed |